Hepatitis C Virus (HCV) Genotypes in the Caribbean Island of Martinique: Evidence for a Large Radiation of HCV-2 and for a Recent Introduction from Europe of HCV-4
Jenny Martial, Raymond Césaire(Institut Pasteur), Yoann Morice(Université Sorbonne Paris Nord), André Edouard(Service de la Santé Publique), Paul Dény(Centre National de la Recherche Scientifique), Philippe Garsaud, André Cabie, R. Chout(Centre Hospitalier Universitaire de Martinique), Sylvie Abel(Hospital for Tropical Diseases), Emmanuel Gordien(Inserm), Odile Béra, Serge Pierre‐Louis, Frédéric Lombard(Service de la Santé Publique), Christelle Rat(Service de la Santé Publique)
Cited by 47
Related Papers
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2017|249
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up
|Hepatology|2006|238
Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a <i>Deltavirus</i> Genus of at Least Seven Major Clades
|Journal of Virology|2004|221
Eighth Major Clade for Hepatitis Delta Virus
|Emerging infectious diseases|2006|206